Amy D. Waterman

Amy D. Waterman

Auto-generated profile, based on publicly available information

Amy D. Waterman

J.C. Walter Jr. Transplant Center, Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2001 in JAMA
Verified
Journal Article
Closed access
PDF file
BGBrian Gage
Brian Gage
AWAmy D. Waterman
Amy D. Waterman
WSWilliam Shannon
William Shannon
MBMichael Boechler
Michael Boechler
MRMichael W. Rich
Michael W. Rich
MRMartha J. Radford
Martha J. Radford
Research from JAMA — Validation of Clinical Classification Schemes for Predicting Stroke — Results From the National Registry of Atrial Fibrillation — ContextPatients who have atrial fibrillation (AF) have an increased risk of stroke, but their absolute rate of stroke depends on age and comorbid conditions.ObjectiveTo assess the predictive value of classification schemes that estimate stroke risk in patients with AF.Design, Setting, and PatientsTwo existing classification schemes were combined into a new stroke-risk scheme, the CHADS2 index, and all 3 classification schemes were validated. The CHADS2 was formed by assigning 1 point each for the presence of congestive heart failure, hypertension, age 75 years or older, and diabetes mellitus and by assigning 2 points for history of stroke or transient ischemic attack. Data from peer review organizations representing 7 states were used to assemble a National Registry of AF (NRAF) consisting of 1733 Medicare beneficiaries aged 65 to 95 years who had nonrheumatic AF and were not prescribed warfarin at hospital discharge.Main Outcome MeasureHospitalization for ischemic stroke, determined by Medicare claims data.ResultsDuring 2121 patient-years of follow-up, 94 patients were readmitted to the hospital for ischemic stroke (stroke rate, 4.4 per 100 patient-years). As indicated by a c statistic greater than 0.5, the 2 existing classification schemes predicted stroke better than chance: c of 0.68 (95% confidence interval [CI], 0.65-0.71) for the scheme developed by the Atrial Fibrillation Investigators (AFI) and c of 0.74 (95% CI, 0.71-0.76) for the Stroke Prevention in Atrial Fibrillation (SPAF) III scheme. However, with a c statistic of 0.82 (95% CI, 0.80-0.84), the CHADS2 index was the most accurate predictor of stroke. The stroke rate per 100 patient-years without antithrombotic therapy increased by a factor of 1.5 (95% CI, 1.3-1.7) for each 1-point increase in the CHADS2 score: 1.9 (95% CI, 1.2-3.0) for a score of 0; 2.8 (95% CI, 2.0-3.8) for 1; 4.0 (95% CI, 3.1-5.1) for 2; 5.9 (95% CI, 4.6-7.3) for 3; 8.5 (95% CI, 6.3-11.1) for 4; 12.5 (95% CI, 8.2-17.5) for 5; and 18.2 (95% CI, 10.5-27.4) for 6.ConclusionThe 2 existing classification schemes and especially a new stroke risk index, CHADS2, can quantify risk of stroke for patients who have AF and may aid in selection of antithrombotic therapy.

1 March 2006 in American Heart Journal
Verified
Journal Article
Closed access
BGBrian Gage
Brian Gage
YYYan Yan
Yan Yan
PMPaul E. Milligan
Paul E. Milligan
AWAmy D. Waterman
Amy D. Waterman
RCRobert Culverhouse
Robert Culverhouse
MRMartha J. Radford
Martha J. Radford

26 February 2003 in JAMA
Verified
Journal Article
Open access
PDF file
TGThomas H. Gallagher
Thomas H. Gallagher
AWAmy D. Waterman
Amy D. Waterman
AEAlison G. Ebers
Alison G. Ebers
VFVictoria J. Fraser
Victoria J. Fraser
WLWendy Levinson
Wendy Levinson
Health care institutions nationwide are developing ambitious programs to prevent medical errors.1,2 Yet, despite our best efforts, medical errors will inevitably occur.3 An important component of the response to an error is deciding whether and how to tell the patient about what happened. Disclosing medical errors respects patient autonomy and truth-telling, is desired by patients, and has been endorsed by multiple ethicists and professional organizations.4-19 In addition, hospital accreditation standards and some state laws now require that patients be informed about "unanticipated outcomes" in their care.20-23

1 May 2005 in Medical Care
Verified
Journal Article
Closed access
EBElena Birman-Deych
Elena Birman-Deych
AWAmy D. Waterman
Amy D. Waterman
YYYan Yan
Yan Yan
DNDavid S. Nilasena
David S. Nilasena
MRMartha J. Radford
Martha J. Radford
BGBrian F. Gage
Brian F. Gage
We sought to determine which ICD-9-CM codes in Medicare Part A data identify cardiovascular and stroke risk factors. This was a cross-sectional study comparing ICD-9-CM data to structured medical record review from 23,657 Medicare beneficiaries aged 20 to 105 years who had atrial fibrillation. Quality improvement organizations used standardized abstraction instruments to determine the presence of 9 cardiovascular and stroke risk factors. Using the chart abstractions as the gold standard, we assessed the accuracy of ICD-9-CM codes to identify these risk factors. ICD-9-CM codes for all risk factors had high specificity (>0.95) and low sensitivity (≤0.76). The positive predictive values were greater than 0.95 for 5 common, chronic risk factors—coronary artery disease, stroke/transient ischemic attack, heart failure, diabetes, and hypertension. The sixth common risk factor, valvular heart disease, had a positive predictive value of 0.93. For all 6 common risk factors, negative predictive values ranged from 0.52 to 0.91. The rare risk factors—arterial peripheral embolus, intracranial hemorrhage, and deep venous thrombosis—had high negative predictive value (≥0.98) but moderate positive predictive values (range, 0.54–0.77) in this population. Using ICD-9-CM codes alone, heart failure, coronary artery disease, diabetes, hypertension, and stroke can be ruled in but not necessarily ruled out. Where feasible, review of additional data (eg, physician notes or imaging studies) should be used to confirm the diagnosis of valvular disease, arterial peripheral embolus, intracranial hemorrhage, and deep venous thrombosis.

1 November 2001 in ACC Current Journal Review
Verified
Journal Article
Closed access
BGB.F Gage
B.F Gage
AWA.D Waterman
A.D Waterman
WSW Shannon
W Shannon
MBM Boechler
M Boechler
MRM.W Rich
M.W Rich
MRM.J Radford
M.J Radford

14 August 2006 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
TGThomas H. Gallagher
Thomas H. Gallagher
JGJane M. Garbutt
Jane M. Garbutt
AWAmy D. Waterman
Amy D. Waterman
DFDavid R. Flum
David R. Flum
ELEric B. Larson
Eric B. Larson
WLWendy Levinson
Wendy Levinson
A sizable gap exists between patients' desire to be told about medical errors and current practice, with studies1-5 suggesting that less than half of harmful errors are disclosed to patients. This failure to disclose errors could diminish patient trust and satisfaction and may increase the likelihood of malpractice claims.6-11